Dual blockade of DPP-4 and CXCL12/CXCR4 axes synergistically protects podocytes in lupus nephritis.
Saved in:
| Title: | Dual blockade of DPP-4 and CXCL12/CXCR4 axes synergistically protects podocytes in lupus nephritis. |
|---|---|
| Authors: | Hu HM; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Zhengzhou University, Zhengzhou, China., Li YC; Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China., Zhang YM; Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China., Zhu TY; Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China., Yong WJ; Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China., Gan YH; Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China., Liu C; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Zhengzhou University, Zhengzhou, China., Duan RY; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Zhengzhou University, Zhengzhou, China., Xu HD; Zhengzhou University, Zhengzhou, China.; Ministry of Education of China, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, China.; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China., Zhao ZZ; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Zhengzhou University, Zhengzhou, China.; Laboratory of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Qi YY; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Zhengzhou University, Zhengzhou, China.; Laboratory of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 Jan 12; Vol. 16, pp. 1732243. Date of Electronic Publication: 2026 Jan 12 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2025.1732243 |
